tradingkey.logo

IM Cannabis Corp

IMCC
1.280USD
-0.110-7.91%
Cierre 11/04, 16:00ETCotizaciones retrasadas 15 min
5.18MCap. mercado
PérdidaP/E TTM

IM Cannabis Corp

1.280
-0.110-7.91%

Más Datos de IM Cannabis Corp Compañía

IM Cannabis Corp. is a Canada-based international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel. In Germany, the Company operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. It offers four different product lines, leading with the Craft Collection which offers the highest quality Canadian craft cannabis flower. The Company's other product lines include Top-Shelf Collection, Signature Collection and Full Spectrum Extracts. The Company's brands include The WAGNERS, BLKMKT, LOT420, and The PICO collection (minis).

Información de IM Cannabis Corp

Símbolo de cotizaciónIMCC
Nombre de la empresaIM Cannabis Corp
Fecha de salida a bolsaNov 05, 2019
Director ejecutivoMr. Eyal Fisher
Número de empleados55
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 05
DirecciónKibbutz Glil Yam
Ciudad
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísIsrael
Código postal4690500
Teléfono14162564202
Sitio Webhttps://imcannabis.com/
Símbolo de cotizaciónIMCC
Fecha de salida a bolsaNov 05, 2019
Director ejecutivoMr. Eyal Fisher

Ejecutivos de IM Cannabis Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Oren Shuster
Mr. Oren Shuster
Chief Executive Officer, Director
Chief Executive Officer, Director
898.35K
--
Ms. Einat Zakariya
Ms. Einat Zakariya
Independent Director
Independent Director
10.20K
--
Mr. Richard Balla
Mr. Richard Balla
Chief Executive Officer of Adjupharm
Chief Executive Officer of Adjupharm
625.00
-28.57%
Mr. Eliyahu (Eli) Zamir
Mr. Eliyahu (Eli) Zamir
Director
Director
--
--
Mr. Asaf Yitzhaik
Mr. Asaf Yitzhaik
Director
Director
--
--
Mrs. Michal Lebovitz Nissimov
Mrs. Michal Lebovitz Nissimov
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Eyal Fisher
Mr. Eyal Fisher
Chief Executive Officer of IMC Holdings and each of the Israeli Subsidiaries
Chief Executive Officer of IMC Holdings and each of the Israeli Subsidiaries
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Uri Birenberg
Mr. Uri Birenberg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Moti Marcus
Mr. Moti Marcus
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Oren Shuster
Mr. Oren Shuster
Chief Executive Officer, Director
Chief Executive Officer, Director
898.35K
--
Ms. Einat Zakariya
Ms. Einat Zakariya
Independent Director
Independent Director
10.20K
--
Mr. Richard Balla
Mr. Richard Balla
Chief Executive Officer of Adjupharm
Chief Executive Officer of Adjupharm
625.00
-28.57%
Mr. Eliyahu (Eli) Zamir
Mr. Eliyahu (Eli) Zamir
Director
Director
--
--
Mr. Asaf Yitzhaik
Mr. Asaf Yitzhaik
Director
Director
--
--
Mrs. Michal Lebovitz Nissimov
Mrs. Michal Lebovitz Nissimov
General Counsel, Secretary
General Counsel, Secretary
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2022Q1
FY2021
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Germany
6.80M
53.58%
Israel
5.89M
46.42%
Adjustments
0.00
0.00%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 25 de oct
Actualizado: sáb., 25 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Shuster (Oren)
17.12%
Molho (Ran)
13.45%
Gabay (Rafael)
9.88%
Lustig (Marc)
2.96%
AdvisorShares Investments, LLC
2.00%
Otro
54.59%
Accionistas
Accionistas
Proporción
Shuster (Oren)
17.12%
Molho (Ran)
13.45%
Gabay (Rafael)
9.88%
Lustig (Marc)
2.96%
AdvisorShares Investments, LLC
2.00%
Otro
54.59%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
44.66%
Investment Advisor
4.01%
Research Firm
0.24%
Hedge Fund
0.23%
Investment Advisor/Hedge Fund
0.10%
Otro
50.76%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
33
240.32K
4.58%
-21.61K
2025Q2
38
2.47M
48.05%
+959.10K
2025Q1
38
1.47M
47.74%
-160.92K
2024Q4
42
1.47M
47.79%
+350.95K
2024Q3
48
940.41K
38.51%
-167.62K
2024Q2
52
942.46K
38.60%
-171.69K
2024Q1
56
979.54K
40.26%
-121.50K
2023Q4
56
985.22K
44.75%
-141.95K
2023Q3
65
1.02M
46.98%
-107.12K
2023Q2
70
1.00M
46.23%
+11.21K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Shuster (Oren)
898.35K
17.12%
--
--
Aug 14, 2025
Molho (Ran)
705.67K
13.45%
+705.67K
--
Jun 24, 2025
Gabay (Rafael)
518.52K
9.88%
--
--
Aug 14, 2025
Lustig (Marc)
155.11K
2.96%
--
--
Dec 31, 2024
AdvisorShares Investments, LLC
104.88K
2%
+800.00
+0.77%
Jun 30, 2025
Heron Bay Capital Management, LLC
78.79K
1.5%
+78.79K
--
Jun 30, 2025
Arbel (Shmulik)
54.86K
1.05%
--
--
Mar 31, 2025
Citadel Advisors LLC
12.25K
0.23%
+12.25K
--
Jun 30, 2025
BMO Nesbitt Burns Inc.
12.18K
0.23%
-307.00
-2.46%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
AdvisorShares Pure Cannabis ETF
0.42%
Amplify Seymour Cannabis ETF
0%
AdvisorShares Pure Cannabis ETF
Proporción0.42%
Amplify Seymour Cannabis ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Nov 15, 2022
Merger
10→1
Nov 15, 2022
Merger
10→1
Fecha
Tipo
Relación
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Nov 15, 2022
Merger
10→1
Nov 15, 2022
Merger
10→1
Nov 15, 2022
Merger
10→1
Nov 15, 2022
Merger
10→1
KeyAI